4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-053206
EVP, R&D & Chief Scientific Of sold 6,000 shares at $15.30 ($91,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2017-09-15 | Sale | −6,000 | $15.30 | $91,800 | 349,305 | D |
| Open-market sales · 6,000 sh · avg $15.30 · $91,800 | |||||||
Loading xslF345X03/doc4.xml…